Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Go back to Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Better Therapeutics, Inc. (BTTX) Tops Q2 EPS by 3c

August 11, 2022 7:38 AM EDT

Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q2 EPS of ($0.42), $0.03 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.

... More